Targeted Oncology24d
A Real-Time Cancer-Detecting System for Breast Cancer Goes Live
The LumiSystem is now commercially available in the US for breast cancer detection. The device uses fluorescence imaging technology during lumpectomy, offering a more complete resection vs other ...
abc2727d
Lumicell Announces U.S. Launch and First Commercial Use of LumiSystem™, Pioneering Real-Time Detection of Residual Breast Cancer During Lumpectomy
NEWTON, Mass., Jan. 27, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today ...
Yahoo Finance27d
Lumicell Announces U.S. Launch and First Commercial Use of LumiSystem™, Pioneering Real-Time Detection of Residual Breast Cancer During Lumpectomy
Unlike other detection systems that only evaluate tissue after it has been surgically removed, LumiSystem™ allows for real-time visualization of cancer inside the breast. This enables surgeons ...
BioSpace27d
Lumicell Announces U.S. Launch and First Commercial Use of LumiSystem™, Pioneering Real-Time Detection of Residual Breast Cancer During Lumpectomy
Jan. 27, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the U.S. commercial availability and ...
Targeted Oncology1mon
Elinzanetant Shows VMS Reduction in Women With or at High Risk of HR+ Breast Cancer
Elinzanetant reduced vasomotor symptoms frequency and severity in women with or at high risk of HR-positive breast cancer in the OASIS 4 trial. The phase 3 OASIS 4 trial (NCT05587296) of elinzanetant ...